Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
McKinsey
Dow
Merck
McKesson

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Litigation Details for JANSSEN PHARMACEUTICALS, INC. v. WATSON LABORATORIES, INC. (D.N.J. 2008)

See Plans and Pricing

« Back to Dashboard

JANSSEN PHARMACEUTICALS, INC. v. WATSON LABORATORIES, INC. (D.N.J. 2008)

Docket   Start Trial Date Filed 2008-10-16
Court District Court, D. New Jersey Date Terminated 2012-09-11
Cause 35:271 Patent Infringement Assigned To Stanley R. Chesler
Jury Demand None Referred To Magistrate Judge Cathy L. Wald
Parties JANSSEN PHARMACEUTICALS, INC.; JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, LLC; LUPIN LTD.; LUPIN PHARMACEUTICALS, INC.; ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC.; SANDOZ, INC.; WATSON LABORATORIES, INC.; WATSON PHARMACEUTICALS, INC.
Patents 4,530,839; 4,544,554; 4,616,006; 4,628,051; 6,214,815
Attorneys ANDREW T. BERRY; CARISSA L. RODRIGUE; CHARLES A. WEISS; CHRISTINA LYNN SAVERIANO; CYNTHIA STENCEL BETZ; ERIC I. ABRAHAM; JEFFREY S. GINSBERG; JOHN EDMUND FLAHERTY; KAREN A. CONFOY; MARK H. ANANIA; ROBERT JOSEPH FETTWEIS; SARA MERIN; WILLIAM J. HELLER
Firms McCarter and English, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in JANSSEN PHARMACEUTICALS, INC. v. WATSON LABORATORIES, INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for JANSSEN PHARMACEUTICALS, INC. v. WATSON LABORATORIES, INC. (D.N.J. 2008)

Date Filed Document No. Description Snippet Link To Document
2011-01-25 168 nonstatutory double patenting, in view of U.S. Patent No. 4,616,006 (the “’006 patent”). Ortho has moved…States Patent and Trademark Office (“PTO”) issued U.S. Patent No. 6,214,815 (the “’815 patent”). Ortho… ’815 patent due to nonstatutory double patenting, in view of claims 7 and 9 of the ’006 patent. The…commonly owned patent is invalid for obvious-type double patenting. A later patent claim is not… in the ‘006 patent and 25 micrograms in the ’815 patent. Claim 9 in the ‘006 patent depends on claim External link to document
2012-09-11 308 4,544,554 (the “’554 patent”), and U.S. Patent No. 4,530,839 (the “’839 patent”) (collectively, … (the “’006 patent”), U.S. Patent No. 4,628,051 (the “’051 patent”), U.S. Patent No. 4,544,554… this patent on June 9, 1999. The ’815 patent issued on April 10, 2001. The ’815 patent is due…554 patents and the one claimed in claims 1 and 4 of the ’815 patent is that the prior patents disclose…554 patent; for claim 4 of the ’815 patent, the inquiry begins with claim 9 of the ’006 patent. These External link to document
2012-09-11 309 infringement of the valid claims 1 and 4 of U.S. Patent No. 6,214,815, and Judgment is hereby entered accordingly…infringement, asserting the invalidity of the 815 patent, is hereby entered in Plaintiffs favor; that Defendants…11 September 2012 2:08-cv-05103-SRC-CLW Patent None District Court, D. New Jersey External link to document
2012-09-12 313 infringement of the valid claims 1 and 4 of U.S. Patent No. 6,214,815, etc., Signed by Judge Stanley R. Chesler…infringement, asserting the invalidity of the '815 patent in favor of Pltfs'; that Defts' filing of its Paragraph…11 September 2012 2:08-cv-05103-SRC-CLW Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Merck
Baxter
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.